EP 2160377 A1 20100310 - TARGETING DIAZO PRODRUGS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
Title (en)
TARGETING DIAZO PRODRUGS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
Title (de)
TARGETING VON DIAZO-PRODRUGS ZUR BEHANDLUNG VON MAGEN-DARM-ERKRANKUNGEN
Title (fr)
CIBLAGE DE PROMÉDICAMENTS DIAZO POUR LE TRAITEMENT DE MALADIES GASTRO-INTESTINALES
Publication
Application
Priority
- EP 2008058338 W 20080627
- IE 20070475 A 20070629
- US 94710407 P 20070629
Abstract (en)
[origin: WO2009003970A1] Provided herein are compounds, compositions and methods for decreasing NFkB DNA-binding activity in a patient comprising administering of a therapeutically effective amount of a compound or composition of the application to the patient to reduce, alleviate or treat various gastrointestinal diseases, such as inflammatory bowel disease (IBD).
IPC 8 full level
C07C 245/08 (2006.01); A61K 31/575 (2006.01); A61P 1/12 (2006.01); C07J 9/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/12 (2017.12); A61P 19/08 (2017.12); A61P 29/00 (2017.12); A61P 33/00 (2017.12); A61P 33/04 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07C 245/08 (2013.01); C07C 271/20 (2013.01); C07C 309/46 (2013.01); C07C 309/69 (2013.01); C07D 319/08 (2013.01); C07D 407/12 (2013.01); C07F 9/4056 (2013.01); C07F 9/4075 (2013.01); C07C 2603/40 (2017.04)
Citation (search report)
See references of WO 2009003970A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009003970 A1 20090108; AU 2008270363 A1 20090108; CA 2691716 A1 20090108; CN 101801919 A 20100811; EP 2160377 A1 20100310; JP 2010531845 A 20100930
DOCDB simple family (application)
EP 2008058338 W 20080627; AU 2008270363 A 20080627; CA 2691716 A 20080627; CN 200880022191 A 20080627; EP 08774496 A 20080627; JP 2010513951 A 20080627